{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:40:13Z","timestamp":1790433613106,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Few studies have attempted to evaluate the early efficacy of first\u2010generation somatostatin analogues in somatotroph macroadenomas.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the short\u2010term efficacy of primary therapy with lanreotide 120\u2009mg at 1 and 3 months on tumour shrinkage and ophthalmologic symptoms in newly diagnosed patients with acromegaly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Patients<\/jats:title><jats:p>This single\u2010centre retrospective study included 21 patients with de novo acromegaly resulting from pituitary macroadenoma, with optic chiasm compression (Grade\u2009\u2264\u20092) and\/or cavernous sinus invasion, treated with a monthly injection of lanreotide 120\u2009mg. Clinical, hormonal, ophthalmologic and magnetic resonance imaging scan evaluations were conducted after the first and the third months of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Tumour volume reduction was more pronounced at 1 month; mean volume change: \u221231.4\u2009\u00b1\u200919.5%, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.0001\u00a0than between the first and third month of treatment; mean volume reduction: \u221220.6\u2009\u00b1\u200913.4%, <jats:italic>p<\/jats:italic>\u2009=\u2009.0009. The mean volume change between baseline and the third month was \u2212 46.4\u2009\u00b1\u200921.6, (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.0001). A significant volume reduction (\u226525%) was observed in 61.9% of individuals (13\/21) at the first month. Among 14 individuals with optic chiasm compression and visual field defects, visual field normalization or improvement were observed in seven cases (50%), stabilization in four cases (28.5%), and mild worsening in three cases (21.4%) at 1 month. The decrease in growth hormone and IGF\u20101 serum values was significant at 1 month.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Primary treatment with lanreotide 120\u2009mg in patients with somatotroph macroadenomas provides early significant tumour shrinkage with rapid improvement of visual symptoms at the end of the first month in 50% of patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.14748","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T02:08:53Z","timestamp":1650938933000},"page":"52-63","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of lanreotide 120\u2009mg primary therapy on tumour shrinkage and ophthalmologic symptoms in acromegaly after 1 month"],"prefix":"10.1111","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-8344","authenticated-orcid":false,"given":"Hamza","family":"Benderradji","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology, and Metabolism Lille University Hospital Lille France"},{"name":"University of Lille, Inserm, CHU Lille Lille Neuroscience &amp; Cognition UMR\u2010S1172 Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Vernotte","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, and Metabolism Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-0696","authenticated-orcid":false,"given":"Gustave","family":"Soto Ares","sequence":"additional","affiliation":[{"name":"Department of Radiology Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Woillez","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6031-4816","authenticated-orcid":false,"given":"Arnaud","family":"Jannin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, and Metabolism Lille University Hospital Lille France"},{"name":"University of Lille, Inserm U 1277 Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Perbet","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm, CHU Lille Lille Neuroscience &amp; Cognition UMR\u2010S1172 Lille France"},{"name":"Department of Pathology Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5090-6252","authenticated-orcid":false,"given":"M\u00e9lodie\u2010Anne","family":"Karnoub","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Soudan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry &amp; Hormonology Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1763-2445","authenticated-orcid":false,"given":"Richard","family":"Assaker","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-4230","authenticated-orcid":false,"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm, CHU Lille Lille Neuroscience &amp; Cognition UMR\u2010S1172 Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-3615","authenticated-orcid":false,"given":"Vincent","family":"Prevot","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm, CHU Lille Lille Neuroscience &amp; Cognition UMR\u2010S1172 Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-6461","authenticated-orcid":false,"given":"Claude\u2010Alain","family":"Maurage","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm, CHU Lille Lille Neuroscience &amp; Cognition UMR\u2010S1172 Lille France"},{"name":"Department of Pathology Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-4487","authenticated-orcid":false,"given":"Pascal","family":"Pigny","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm U 1277 Lille France"},{"name":"Department of Biochemistry &amp; Hormonology Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-0463","authenticated-orcid":false,"given":"Marie\u2010Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, and Metabolism Lille University Hospital Lille France"},{"name":"University of Lille, Inserm, U1190, EGID Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Merlen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, and Metabolism Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cortet","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, and Metabolism Lille University Hospital Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01091-7"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0315"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323001204000213"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-203"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030266"},{"issue":"11","key":"e_1_2_9_8_1","first-page":"4099","article-title":"Two\u2010year follow\u2010up of acromegalic patients treated with slow release lanreotide (30 mg)","volume":"85","author":"Baldelli R","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01741.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03503.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3318"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036411"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0169-z"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0305"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0420-x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2015.04.006"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199207000-00004"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0840"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199310000-00008"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.JNS141083"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-16-0356"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700165"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005277936"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0613-6"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2015.02.001"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2084"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1093"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100541"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00135"},{"issue":"2","key":"e_1_2_9_31_1","first-page":"781","article-title":"Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes","volume":"85","author":"Jaquet P","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01524"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04286.x"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2282020695"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.14748","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cen.14748","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.14748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T07:32:30Z","timestamp":1692862350000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.14748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1111\/cen.14748"],"URL":"https:\/\/doi.org\/10.1111\/cen.14748","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"2022-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}